TLR2 inhibition reprograms the tumor microenvironment and delays progression of recurrent ovarian cancer in vivo

被引：0
|
作者：
Alvero, A. [1 ]
Pitruzzello, M. [1 ]
Keogh, B. [2 ]
Mcguirk, P. [2 ]
Reilly, M. [2 ]
Mor, G. [1 ]
机构：
[1] Yale Univ, Ob Gyn, New Haven, CT USA
[2] Opsona Therapeut Ltd, Vivo Pharmacol, Dublin, Ireland
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320 (PB-08
引用
收藏
页码：E107 / E107
页数：1
相关论文
共 50 条
  • [1] BROMODOMAIN INHIBITION IN OVARIAN CANCER AND THE TUMOR MICROENVIRONMENT
    Wilson, Andrew J.
    Hoover, Alyssa
    Harris, Whitney
    Liu, Esther
    Khabele, Dineo
    Yull, Fiona E.
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 172 - 172
  • [2] Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment
    Alexander, Eric T.
    Minton, Allyson R.
    Peters, Molly C.
    van Ryn, Joanne
    Gilmour, Susan K.
    ONCOTARGET, 2016, 7 (51): : 85291 - 85305
  • [3] The effects of Wnt inhibition on tumor progression and the tumor microenvironment in a syngeneic mouse model of ovarian cancer.
    Goldsberry, Whitney
    Doo, David W.
    Meza-Perez, Selene
    Katre, Ashwini A.
    Norian, Lyse
    Randall, Troy
    Arend, Rebecca Christian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Profiling the immune tumor microenvironment in primary and recurrent epithelial ovarian cancer
    Ojalvo, Laureen S.
    Thompson, Elizabeth D.
    Wang, Tian-Li
    Meeker, Alan K.
    Shih, Ie-Ming
    Fader, Amanda N.
    Cimino-Mathews, Ashley
    Emens, Leisha A.
    CANCER RESEARCH, 2017, 77
  • [5] RAS Pathway Inhibition With STAT3 Inhibition Reprograms the Tumor Microenvironment To Enhance Immunotherapy in Pancreatic Cancer
    Lamichhane, P.
    Nagathihalli, N.
    Messaggio, F.
    Dai, X.
    Barretta, J.
    Vansaun, M.
    Merchant, N.
    PANCREAS, 2017, 46 (10) : 1414 - 1414
  • [6] TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
    Chefetz, Ilana
    Alvero, Ayesha B.
    Holmberg, Jennie C.
    Lebowitz, Noah
    Craveiro, Vinicius
    Yang-Hartwich, Yang
    Yin, Gang
    Squillace, Lisa
    Soteras, Marta Gurrea
    Aldo, Paulomi
    Mor, Gil
    CELL CYCLE, 2013, 12 (03) : 511 - 521
  • [7] Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice
    Jun Yan
    Fang Hua
    Han-zhi Liu
    Hong-zheng Yang
    Zhuo-wei Hu
    Acta Pharmacologica Sinica, 2012, 33 : 503 - 512
  • [8] Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice
    Yan, Jun
    Hua, Fang
    Liu, Han-zhi
    Yang, Hong-zheng
    Hu, Zhuo-wei
    ACTA PHARMACOLOGICA SINICA, 2012, 33 (04) : 503 - 512
  • [9] Identification of secretory stromal gene signature of the ovarian tumor microenvironment and implications for ovarian cancer progression
    Thompson, M.
    Albitar, L.
    Ghosh, S.
    Wong, K.
    Welch, W.
    Birrer, M.
    Mok, S.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S129 - S129
  • [10] Tumor immune microenvironment and implications for progression and survival in patients with recurrent endometrial cancer
    Spinosa, Daniel
    Wong, Janice
    Whitaker, Regina
    Strickland, Kyle
    Previs, Rebecca
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S104 - S105
12345